An immunohistochemical study of tumor vascularity and proliferation activity in cholangiocellular carcinoma: Relationship to clinicopathologic factors and prognosis after hepatic resection

Acta Medica Nagasakiensia

Volumn 48, Issue 1-2, 2003, Pages 23-27

  Nanashima, Atsushi ^a   Yoshinaga, Megumi ^a   Yamaguchi, Hiroyuki ^a   Shibasaki, Shinichi ^a   Ide, Noboru ^a   Jo, Kenji ^a   Nakagoe, Tohru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cholangiocellular carcinoma; Hepatic resection; Microvessel count; Proliferating cell nuclear antigen

Indexed keywords

CA 19-9 ANTIGEN; CD34 ANTIGEN; CYCLINE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER RESECTION; MALE; MICROVASCULATURE; PROGNOSIS; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION;

EID: 0141961149     PISSN: 00016055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Valverde A, Bonhomme N, Farges O, Sauvanet A, Flejou JF, Belghiti J: Resection of intrahepatic cholangiocarcinoma: a Western experience. J Hepatobiliary Pancreat Surg 6: 122-7, 1999
2. Isaji S, Kawarada Y, Taoka H, Tabata M, Suzuki H, Yokoi H: Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 6: 108-16, 1999
3. Hirohashi K, Uenishi T, Kubo S, Yamamoto T, Tanaka H, Shuto T, Kinoshita H: Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 49: 326-9, 2002
4. Sun HC, Tang ZY, Li XM, Zhou YN, Sun BR, Ma ZC: Microvessel density of hepatocellular carcinoma: its relationship with prognosis. J Cancer Res Clin Oncol 125: 419-26, 1999
5. Nanashima A, Yamaguchi H, Sawai T, Yamaguchi E, Kidogawa H, Matsuo S, Yasutake T, Tsuji T, Jibiki M, Nakagoe T, Ayabe H: Prognostic factors in hepatic metastases of colorectal carcinoma: immunohistochemical analysis of tumor biological factors. Dig Dis Sci 46: 1623-8, 2001
6. Suehiro T, Matsumata T, Itasaka H, Yamamoto K, Kawahara N, Sugimachi K: Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen. Cancer 1; 76: 399-405, 1995
7. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer (2000) Liver cancer study group of Japan. The Fourth ed. Kanehara & Co., Ltd., Tokyo 11-34
8. Shimada M, Yamashita Y, Aishima S, Shirabe K, Takenaka K, Sugimachi K: Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 88: 1463-6, 2001
9. Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE: Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 227: 70-9, 1998
10. Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M: Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol 69: 162-7, 1998
11. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Miyazaki M: Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 89: 1525-31, 2002
12. Kawarada Y, Yamagiwa K, Das BC: Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 183: 679-85, 2002
13. Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J: Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenterology 49: 311-6, 2002
14. Abou-Rebyeh H, Al-Abadi H, Jonas S, Rotter I, Bechstein WO, Neuhaus P: DNA analysis of cholangiocarcinoma cells: prognostic and clinical importance. Cancer Detect Prev 26: 313-9, 2002
15. Aishima S, Asayama Y, Taguchi K, Sugimachi K, Shirabe K, Shimada M, Sugimachi K, Tsuneyoshi M: The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma. Mod Pathol 15: 1181-90, 2002
16. Taguchi K, Aishima S, Asayama Y, Kajiyama K, Kinukawa N, Shimada M, Sugimachi K, Tsuneyoshi M: The role of p27kip1 protein expression on the biological behavior of intrahepatic cholangiocarcinoma. Hepatology 33: 1118-23, 2001
17. Matsumura N, Yamamoto M, Aruga A, Takasaki K, Nakano M: Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma. Cancer 94: 1770-6, 2002
18. Miwa S, Miyagawa S, Soeda J, Kawasaki S: Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma. Cancer 94: 428-34, 2002
19. Sugimachi K, Aishima S, Taguchi K, Tanaka S, Shimada M, Kajiyama K, Sugimachi K, Tsuneyoshi M: The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma. J Hepatol 35: 74-9, 2001
20. Sternfeld T, Foss HD, Kruschewski M, Runkel N: The prognostic significance of tumor vascularization in patients with localized colorectal cancer. Int J Colorectal Dis 14: 272-6, 1999
21. Rugge M, Sonego F, Pollice L, Perilongo G, Guido M, Basso G, Ninfo V, Pennelli N, Gambini C, Guglielmi M, Fabiano A, Leandro G, Keeling JW: Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology. Liver 18: 128-33, 1998
22. Yamaguchi K, Enjoji M, Tsuneyoshi M: Pancreatoduodenal carcinoma: a clinicopathologic study of 304 patients and immunohistochemical observation for CEA and CA19-9. Surg Oncol 47: 148-54, 1991
23. Ohashi K, Nakajima Y, Kanehiro H, Nakano H: Evaluation of proliferating activity of intrahepatic cholangiocarcinoma using proliferating cell nuclear antigen staining. (Short communication in Japanese) Geka Chiryou 70: 352-353, 1994
24. Knodell RG, Ishak KG, Black WC: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1: 431-5, 1981